{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Emmaus Medical Inc. located in 21250 Hawthorne Boulevard, Suite 800, Torrance, CA, 90503.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/06/22/2020-13315.html","cfr_references":[],"citation":"85 FR 37461","comment_url":null,"comments_close_on":"2020-07-07","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before July 7, 2020 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2020-13315","effective_on":null,"end_page":37461,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/06/22/2020-13315.xml","html_url":"https://www.federalregister.gov/documents/2020/06/22/2020-13315/prospective-grant-of-an-exclusive-patent-license-ointment-for-the-topical-administration-to-ischemic","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-13315?publication_date=2020-06-22","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-06-22/2020-13315/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":285,"last_updated":"2026-07-27 06:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-06-22/pdf/2020-13315.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-13315.pdf?1592570724","publication_date":"2020-06-22","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/06/22/2020-13315.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T07:49:51Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":37461,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Ointment for the Topical Administration to Ischemic Treat and/or Neuropathic Ulcers in Humans","toc_doc":"Ointment for the Topical Administration to Ischemic Treat and/or Neuropathic Ulcers in Humans","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":85}